Home > M&A deals 2021 > Angelini S.p.a. acquires Arvelle Therapeutics International GmbH
Add-on Acquistion · Life Science · January 2021

Angelini S.p.a. acquires Arvelle Therapeutics International GmbH

On January 5, 2021, Angelini S.p.a. acquired Arvelle Therapeutics International GmbH, a life science company in Switzerland, from Andera Partners.

Deal at a glance

AnnouncedJanuary 5, 2021 TypeAdd-on Acquistion TargetArvelle Therapeutics International GmbH Buyer Angelini S.p.a. Seller Andera Partners SectorLife Science LocationSwitzerland ValueMembers only

Target company

Arvelle Therapeutics International GmbH
Switzerland
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Angelini S.p.a.
Company · 3 deals on record
  • 2nd transaction in life science
  • 1st transaction in Switzerland
3deals, all time
2in this sector
2021latest

Seller

Andera Partners
Company · 22 deals on record
22investments
4in this sector
5exits

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

FGen AGSame sector and country · Mar 2022

Questions about this deal

Who acquired Arvelle Therapeutics International GmbH?Angelini S.p.a. acquired Arvelle Therapeutics International GmbH on January 5, 2021.

Who sold Arvelle Therapeutics International GmbH?Andera Partners was the seller.

What type of deal was it?It was a add-on acquistion in the life science sector in 2021.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).